☰

Theodore L. Oliphant, Ph.D. - Publications

Affiliations: 
2007 Washington University, Saint Louis, St. Louis, MO 
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

16 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Strietzel CJ, Bergeron LM, Oliphant T, Mutchler VT, Choromanski LJ, Bainbridge G. In vitro functional characterization of feline IgGs. Veterinary Immunology and Immunopathology. 158: 214-23. PMID 24560097 DOI: 10.1016/J.Vetimm.2014.01.012  0.311
2010 Lightle S, Aykent S, Lacher N, Mitaksov V, Wells K, Zobel J, Oliphant T. Mutations within a human IgG2 antibody form distinct and homogeneous disulfide isomers but do not affect Fc gamma receptor or C1q binding. Protein Science : a Publication of the Protein Society. 19: 753-62. PMID 20120022 DOI: 10.1002/Pro.352  0.417
2009 Sultana H, Foellmer HG, Neelakanta G, Oliphant T, Engle M, Ledizet M, Krishnan MN, Bonafé N, Anthony KG, Marasco WA, Kaplan P, Montgomery RR, Diamond MS, Koski RA, Fikrig E. Fusion loop peptide of the West Nile virus envelope protein is essential for pathogenesis and is recognized by a therapeutic cross-reactive human monoclonal antibody. Journal of Immunology (Baltimore, Md. : 1950). 183: 650-60. PMID 19535627 DOI: 10.4049/Jimmunol.0900093  0.735
2009 Zhang S, Vogt MR, Oliphant T, Engle M, Bovshik EI, Diamond MS, Beasley DW. Development of resistance to passive therapy with a potently neutralizing humanized monoclonal antibody against West Nile virus. The Journal of Infectious Diseases. 200: 202-5. PMID 19527169 DOI: 10.1086/599794  0.703
2009 Vogt MR, Moesker B, Goudsmit J, Jongeneelen M, Austin SK, Oliphant T, Nelson S, Pierson TC, Wilschut J, Throsby M, Diamond MS. Human monoclonal antibodies against West Nile virus induced by natural infection neutralize at a postattachment step. Journal of Virology. 83: 6494-507. PMID 19386704 DOI: 10.1128/Jvi.00286-09  0.733
2009 Diamond MS, Mehlhop E, Oliphant T, Samuel MA. The host immunologic response to West Nile encephalitis virus. Frontiers in Bioscience (Landmark Edition). 14: 3024-34. PMID 19273254 DOI: 10.2741/3432  0.689
2008 Nelson S, Jost CA, Xu Q, Ess J, Martin JE, Oliphant T, Whitehead SS, Durbin AP, Graham BS, Diamond MS, Pierson TC. Maturation of West Nile virus modulates sensitivity to antibody-mediated neutralization. Plos Pathogens. 4: e1000060. PMID 18464894 DOI: 10.1371/Journal.Ppat.1000060  0.734
2007 Pierson TC, Xu Q, Nelson S, Oliphant T, Nybakken GE, Fremont DH, Diamond MS. The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection. Cell Host & Microbe. 1: 135-45. PMID 18005691 DOI: 10.1016/J.Chom.2007.03.002  0.726
2007 Sukupolvi-Petty S, Austin SK, Purtha WE, Oliphant T, Nybakken GE, Schlesinger JJ, Roehrig JT, Gromowski GD, Barrett AD, Fremont DH, Diamond MS. Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes. Journal of Virology. 81: 12816-26. PMID 17881453 DOI: 10.1128/Jvi.00432-07  0.707
2007 Oliphant T, Nybakken GE, Austin SK, Xu Q, Bramson J, Loeb M, Throsby M, Fremont DH, Pierson TC, Diamond MS. Induction of epitope-specific neutralizing antibodies against West Nile virus. Journal of Virology. 81: 11828-39. PMID 17715236 DOI: 10.1128/Jvi.00643-07  0.732
2007 Oliphant T, Diamond MS. The molecular basis of antibody-mediated neutralization of West Nile virus. Expert Opinion On Biological Therapy. 7: 885-92. PMID 17555373 DOI: 10.1517/14712598.7.6.885  0.742
2006 Oliphant T, Nybakken GE, Engle M, Xu Q, Nelson CA, Sukupolvi-Petty S, Marri A, Lachmi BE, Olshevsky U, Fremont DH, Pierson TC, Diamond MS. Antibody recognition and neutralization determinants on domains I and II of West Nile Virus envelope protein. Journal of Virology. 80: 12149-59. PMID 17035317 DOI: 10.1128/Jvi.01732-06  0.732
2005 Gould LH, Sui J, Foellmer H, Oliphant T, Wang T, Ledizet M, Murakami A, Noonan K, Lambeth C, Kar K, Anderson JF, de Silva AM, Diamond MS, Koski RA, Marasco WA, et al. Protective and therapeutic capacity of human single-chain Fv-Fc fusion proteins against West Nile virus. Journal of Virology. 79: 14606-13. PMID 16282460 DOI: 10.1128/Jvi.79.23.14606-14613.2005  0.745
2005 Nybakken GE, Oliphant T, Johnson S, Burke S, Diamond MS, Fremont DH. Structural basis of West Nile virus neutralization by a therapeutic antibody. Nature. 437: 764-9. PMID 16193056 DOI: 10.1038/Nature03956  0.748
2005 Mehlhop E, Whitby K, Oliphant T, Marri A, Engle M, Diamond MS. Complement activation is required for induction of a protective antibody response against West Nile virus infection. Journal of Virology. 79: 7466-77. PMID 15919902 DOI: 10.1128/Jvi.79.12.7466-7477.2005  0.691
2005 Oliphant T, Engle M, Nybakken GE, Doane C, Johnson S, Huang L, Gorlatov S, Mehlhop E, Marri A, Chung KM, Ebel GD, Kramer LD, Fremont DH, Diamond MS. Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus. Nature Medicine. 11: 522-30. PMID 15852016 DOI: 10.1038/Nm1240  0.742
Show low-probability matches.